Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 70518-2590

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 70518-2590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabeprazole Sodium 20mg 70518 2590 01

Rabeprazole Sodium 20mg 70518 2590 01
This appears to be a description of a medication named Rabeprazole Sodium. The medication comes in the form of delayed-release tablets with a strength of 20mg. The packaging contains 30 tablets, with RX-only. The NDC number for the product is 70518-2590-01, and it is manufactured by Ascend Labs in Mentvale, NJ. The package insert includes directions for use, and the medication should be stored between 20-26°C. The description also includes information on who repackaged the medication.*
FDA Label Image

Rabeprazole Sodium 20mg 70518 2590 02

Rabeprazole Sodium 20mg 70518 2590 02
RABEprazole Sodium is a delayed-release 20 mg tablet, with a quantity of 60. It is RX only and should be kept out of reach of children. The package insert should be consulted for directions for use. It should be stored at 20-26°C (63-77°F), excursions permitted to 15-30°C (59-86°F). The product was repackaged by RemedyRepack Inc., Indiana, PA 15701, 724.466.8762. The lot number and expiration date are not available. The source NDC number is 67877-0443-30, and the product NDC number is 70518-2590-02. The manufacturer is Ascend Labs, LLC, Mentvale, NJ.*
FDA Label Image

Rabeprazole Sodium 20mg 70518 2590 03

Rabeprazole Sodium 20mg 70518 2590 03
RABEprazole Sodium is a medication in the form of delayed-release tablets with the strength of 20mg. This is an RX-only drug with a package quantity of 30 tablets. The NDC number for this medication is 70518-2690-03, and it has been manufactured by Ascend Labs LLC in Mentvale, NJ. The lot number and expiry date were not available in the provided text. The package insert should be consulted before using the medication. The drug should be stored between 20-26°C (63-77°F) with excursions allowed up to 15-30°C (59-86°F) and should be kept out of reach of children. The medication was repackaged by RemedyRepack Inc in Indiana, PA.*
FDA Label Image

Rabe-str (Rabe Str)

FDA Label Image

Rabe-str2 (Rabe Str2)

Rabe-str2 (Rabe Str2)
This appears to be a chart or graph showing the mean score of heartburn symptoms for a study involving a placebo, as well as two dosages (10mg and 20mg) of a medication called RAB. The heartburn scores range from 0 to 4, with 0 indicating no symptoms and 4 indicating very severe symptoms. The X-axis represents study days and the Y-axis represents the mean score.*
FDA Label Image

Rabe-str3 (Rabe Str3)

Rabe-str3 (Rabe Str3)
The text provides heartburn scores for two groups; one given placebo and the other given 20mg of RAB. The scores are categorized on a scale of 0 to 4, with 0 being no heartburn and 4 being very severe heartburn. There were 58 individuals who received the placebo and 59 individuals who received RAB. The heartburn scores were recorded on study days 0, 7, 14, 21, and 28. The text includes a graph showing the mean scores for each group on each study day.*
FDA Label Image

Rabe-str4 (Rabe Str4)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication called Rabeprazole Sodium. It is a delayed-release tablet with a strength of 20 mg. It comes in a quantity of 60 and requires a prescription to purchase. The medication is manufactured by Ascend Labs, LLC in Mentvale, NJ. Its National Drug Code (NDC) is 70518-2590-00, and its source NDC is 67877-0443-90. The lot number and expiration date are not available. The medication must be stored at a temperature between 20-26°C (63-77°F), with allowable excursions to 15-30°C (59-86°F). Directions for use are available in the package insert. The medication was repackaged by RemedyRepack Inc. in Indiana, PA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.